AI Visibility for MedSpas: Why ChatGPT Recommends Botox by Brand but Not Your Practice

The shift: from “Botox near me” to “ask the AI”

Medical spas sit at the intersection of healthcare and consumer services — and patient acquisition has always depended on trust, referrals, and search visibility. But the way potential patients research aesthetic treatments is changing fast, and the starting point is migrating from Google to AI chatbots.

Google processes over 1 million searches per month for “Botox near me” alone, with “medspa near me,” “lip filler near me,” and “CoolSculpting near me” adding millions more (SEMrush, 2025). The American Med Spa Association (AmSpa) reports that 72% of medspa patients research treatments online before booking a consultation, and RealSelf data shows that the average aesthetic patient visits 3–5 websites during their research journey.

That online-first behavior is now colliding with the AI chatbot wave.

Gartner forecast in February 2024 that traditional search engine volume will drop 25% by 2026 due to AI chatbots and virtual agents. ChatGPT reached 1.8 billion monthly visits by late 2024, making it one of the top 10 most-visited sites on the planet. Perplexity AI grew to over 100 million monthly visits by Q4 2024. Among adults aged 25–44 — the core demographic for aesthetic treatments — AI chatbot adoption is accelerating: Pew Research Center found 43% of adults aged 18–29 had used ChatGPT by early 2024, with adults 30–49 at 33%.

The queries are changing too. Instead of typing “Botox near me” into Google and getting a map pack of local medspas, a patient asks ChatGPT: “What should I know before getting Botox?” or “What are the best medspa chains in the US?” or “How do I choose between Botox and Dysport?” The AI responds with a narrative answer — mentioning specific products and brands by name — and the patient follows that recommendation without ever seeing your practice in a search result.

The implications for medspas are particularly severe because aesthetic treatments are high-consideration purchases. A single Botox patient represents $1,500–$3,000+ in annual revenue from repeat visits. A filler patient represents $2,000–$5,000. A body contouring patient represents $3,000–$15,000. When AI steers these patients toward national chains or specific product brands without mentioning your practice, the revenue impact is immediate and compounding.

Who AI actually recommends for aesthetic treatments

We asked. Across hundreds of queries to ChatGPT, Perplexity, Gemini, Claude, and Grok, using patient-intent prompts like “What are the best medspas?” “Where should I get Botox?” “What is the best place for laser hair removal?” and “How do I find a good medspa near me?” — the same names appear over and over:

* AI mention rates based on Metricus internal testing across ChatGPT, Perplexity, Gemini, Claude, and Grok using patient-intent queries (2026). Rates reflect how often a brand or entity was named in response to aesthetic treatment and medspa discovery prompts. Methodology details available upon request.

The pattern is stark. Allergan Aesthetics — a division of AbbVie (NYSE: ABBV), with over $5.5 billion in annual aesthetics revenue (AbbVie 2024 annual report) — dominates AI responses because its product brands (Botox, Juvederm, CoolSculpting, Latisse) are synonymous with the treatments themselves. AI recommends the product rather than the provider.

National chains like Ideal Image (L Catterton-backed, approximately 170 locations) and LaserAway (approximately 100 locations across 17 states) appear consistently because they generate massive web presence through multi-state operations, press coverage, and aggressive digital marketing. RealSelf, with over 10 million monthly visitors (SimilarWeb, 2025), functions as the dominant aesthetic marketplace and gets cited as a recommendation source.

Independent medical spas, which represent approximately 70–75% of the 8,000–10,000 medspas operating in the US (AmSpa Industry Study, 2025), are almost never mentioned by name. The AI knows Botox exists. It knows Ideal Image exists. It does not know your practice exists.

Why your medspa is invisible to AI

AI chatbots generate recommendations based on patterns in their training data — billions of web pages, medical publications, Reddit threads, review sites, and news articles. The brands that appear most frequently in that data are the ones AI recommends.

Consider the math:

• Allergan Aesthetics benefits from AbbVie’s $5.3 billion in annual marketing spend (AbbVie 10-K, 2024), generating millions of web mentions across medical journals, news outlets, beauty publications, Reddit discussions, and provider directories.
• Ideal Image generates roughly 1.5–2.5 million monthly website visits (SimilarWeb, 2025) and has extensive media coverage, franchise-related content, and review site presence across 170+ locations.
• RealSelf receives approximately 10 million monthly visits and hosts millions of patient reviews, before/after photos, and treatment pages that AI models extensively index.
• The average independent medspa website receives 500–3,000 monthly visits, has 20–80 Google reviews, and appears on perhaps 5–10 third-party sites (Google Business Profile, Yelp, RealSelf profile, maybe Healthgrades).

That’s a 500x–10,000x gap in web presence. And web presence is what AI systems learn from.

Three specific factors determine whether AI mentions your medspa:

1. Corpus frequency: How often your brand appears across the web. Allergan has tens of millions of mentions through Botox alone — the product is referenced in medical literature, beauty blogs, news articles, and social media at an extraordinary rate. Ideal Image has hundreds of thousands of mentions across review sites, employment listings, franchise discussions, and consumer media. A single-location medspa might have 100–500 total web mentions. The volume gap is enormous.
2. Source authority: AI weights authoritative sources more heavily. Allergan gets coverage in the New England Journal of Medicine, Forbes, Allure, and the Wall Street Journal. National chains get featured in Business Insider, local news affiliates, and industry publications. An independent medspa gets a mention in a local lifestyle blog — which AI may never index. To understand how this works across industries, see our guide on how brands show up in AI recommendations.
3. Content structure: The Princeton/Georgia Tech GEO study (2023) found that content with statistical citations and clear factual claims was up to 40% more likely to be cited by generative AI systems (Aggarwal et al., “GEO: Generative Engine Optimization,” 2023). Most medspa websites are heavy on aspirational imagery and light on the structured, data-rich content that AI can extract and cite — specific pricing, outcome statistics, provider credentials with training volumes, and treatment comparison data.

The aesthetic medicine industry has an additional challenge: AI tends to recommend products rather than providers. A patient asks “How do I get rid of forehead wrinkles?” and AI responds with “Botox (onabotulinumtoxinA) is the most common treatment...” — mentioning the product and its manufacturer but not the practice that actually administers it. This product-over-provider bias means even well-known medspas struggle for AI visibility.

What AI gets wrong about medspa treatments

Even when AI does discuss aesthetic treatments or mention specific providers, it frequently gets critical facts wrong. Our testing found AI gives incorrect or outdated information in approximately 40–50% of medspa-specific queries. In an industry where medical safety and patient expectations are paramount, accuracy isn’t optional. For more on this problem, see our deep dive on fixing AI hallucinations about your brand.

The most common errors we find in AI responses about medspa businesses:

Pricing ranges

Medspa treatment pricing varies enormously by geography, provider experience, and product used. AI routinely gets this wrong in ways that damage patient expectations and provider credibility. Botox pricing ranges from $10 to $25 per unit depending on market, with the average treatment requiring 20–60 units — meaning actual treatment costs range from $200 to $1,500. AI often cites flat-rate national averages ($300–$600 per area) that don’t reflect per-unit pricing models (ASAPS Procedural Statistics, 2024). For dermal fillers, the gap is worse: a syringe of Juvederm ranges from $500 to $1,200+ depending on the specific product line (Voluma vs. Ultra vs. Volbella) and geographic market, but AI frequently provides a single number. CoolSculpting sessions range from $2,000 to $4,000 per area according to the American Society of Plastic Surgeons (ASPS), but AI often quotes the outdated per-applicator pricing model that Allergan replaced.

Treatment safety and contraindications

This is where AI errors become potentially dangerous. AI sometimes conflates treatment protocols — suggesting that Botox and fillers can be administered in the same session without noting that the approach depends on the specific areas being treated and the provider’s clinical judgment. AI occasionally omits critical contraindications: patients with autoimmune disorders require special consideration for injectable treatments, and certain medications (blood thinners, for example) affect treatment planning. The American Society for Aesthetic Plastic Surgery (ASAPS) emphasizes that treatment planning should be individualized, but AI provides generic protocols.

Provider credentials and scope of practice

Medspa regulations vary dramatically by state. In some states, only physicians can own medspas. In others, nurse practitioners or physician assistants can own and operate them independently. AI frequently provides generic credentialing advice (“make sure your provider is board-certified”) without specifying board-certified in what. A board-certified dermatologist, a board-certified plastic surgeon, and a board-certified family medicine physician all have different training relevant to aesthetic procedures. AmSpa reports that state medical board complaints related to medspas increased 28% between 2020 and 2024, making accurate provider credential information critical for patient safety.

Recovery times and expected results

AI routinely understates recovery times for more aggressive treatments. Laser skin resurfacing (ablative CO2 or erbium) requires 7–14 days of significant downtime (ASPS), but AI sometimes quotes “a few days.” Chemical peels range from zero downtime (superficial) to 2+ weeks (deep phenol peels), and AI frequently fails to distinguish between peel depths. For injectables, AI often omits the fact that filler results take 2–4 weeks to fully settle and that initial swelling can be significant, leading to unrealistic patient expectations.

Technology and device accuracy

The aesthetic device market evolves rapidly. AI training data often reflects outdated device generations or discontinued technologies. AI may recommend treatments using devices no longer considered standard of care, or fail to distinguish between substantially different technologies marketed under similar names. For example, older-generation laser hair removal technology has different efficacy profiles across skin types compared to current diode and Nd:YAG platforms, but AI frequently treats “laser hair removal” as a single homogeneous technology.

The $20 billion+ market AI is reshaping

The medical spa and aesthetic medicine market is massive, fast-growing, and increasingly consumer-driven:

• The US medical spa market exceeded $20 billion in 2025 and is projected to reach $45.5 billion by 2030, growing at a CAGR of 14.6% (Grand View Research, 2025).
• The global aesthetic medicine market surpassed $100 billion in 2025, encompassing injectables, laser treatments, body contouring, and skin rejuvenation (McKinsey & Company, “The Beauty Market in 2025,” 2025).
• Allergan Aesthetics (AbbVie) generated $5.5 billion in aesthetics revenue in 2024 (AbbVie annual report), with Botox alone accounting for over $2.7 billion in US sales.
• Galderma, which IPO’d in March 2024 at a $20 billion valuation, reported $4.4 billion in total revenue (2024 annual report), with its aesthetics division (Restylane, Dysport, Sculptra) growing at 15%+ annually.
• The neurotoxin market (Botox, Dysport, Xeomin, Jeuveau, Daxxify) alone reached approximately $4.8 billion in US revenue in 2024 (ASAPS/Deloitte estimates), with Botox commanding roughly 70% market share.
• AmSpa estimates 8,000–10,000 medspas are currently operating in the US (2025 Industry Study), up from approximately 5,400 in 2018 — a 65%+ increase in seven years.
• The average medspa generates $1.2–$2.5 million in annual revenue (AmSpa benchmarking data, 2025), with top performers exceeding $5 million.

The industry’s growth is driven by demographic tailwinds: millennials and Gen Z are entering the aesthetic treatment market earlier and in greater numbers than any previous generation. ASAPS reports that patients aged 19–34 now account for 24% of all minimally invasive aesthetic procedures, up from 18% in 2019. These younger patients are also the most likely to use AI chatbots for research.

Yet despite its size and growth, the medspa industry has a structural digital marketing gap. A 2024 Deloitte analysis of the aesthetic medicine sector found that independent medspas spend an average of 5–8% of revenue on marketing, compared to 12–15% for national chains with dedicated digital marketing teams. Most single-location medspas rely on a combination of Google Ads, Instagram, word of mouth, and Google Business Profile for patient acquisition — with little to no content strategy that would build AI visibility.

This creates the same dynamic we see across local service industries: a massive market with fragmented, small operators and a handful of well-funded national brands and product manufacturers with outsized web presence. For more context on why these dynamics play out the same way in other sectors, see why B2B SaaS brands are invisible in ChatGPT.

The local medspa vs. national chain problem

The tension between local medspas and national chains is the defining competitive dynamic in the industry — and AI is making it dramatically worse.

Consider how the competitive landscape works:

• Ideal Image operates approximately 170 locations across 34 states, backed by L Catterton (LVMH’s private equity arm). It generates extensive web presence through multi-state operations, national advertising campaigns, employment listings, and consumer review volume across every major platform.
• LaserAway operates approximately 100 locations across 17 states. Founded in 2006, it has aggressively built its digital presence with celebrity partnerships, influencer marketing, and social media content that generates millions of branded impressions.
• Sono Bello operates approximately 100 locations focused on body contouring and has built brand recognition through national television and digital advertising spend estimated at $30–$50 million annually (Kantar media estimates).
• SkinSpirit, with approximately 40 locations, has attracted private equity investment and is expanding rapidly, generating increasing web presence with each new market entry.
• Ever/Body, the New York-based chain backed by $38 million in venture capital, generates disproportionate media coverage from beauty and business publications.

An independent medspa competing in any of these chains’ markets faces a fundamental AI visibility gap. The chain has 100–170 locations, each generating reviews, social mentions, and directory listings. The chain has national press coverage. The chain has a marketing team producing content at scale. The chain’s website has thousands of pages of indexed content.

On Google, local medspas could still compete: the Google Maps 3-pack actively favors proximity, and a well-optimized local practice with strong reviews could outrank a national chain in local search. In AI chatbot responses, proximity is irrelevant. The same national brands appear whether a patient is in Beverly Hills or Boise.

The gap between Google and AI recommendations for medspas is particularly wide because AI has a product-brand bias. On Google, “Botox near me” returns local providers. On ChatGPT, “Tell me about Botox” returns information about the product, its manufacturer, and possibly national chains that advertise it — with no local provider in sight. Learn more about how we measure AI visibility across these channels.

How patients actually choose a medspa — and what AI misses

Understanding what drives aesthetic patients reveals the depth of AI’s blindspot. RealSelf patient survey data (2024), AmSpa consumer research (2025), and ASAPS procedural statistics consistently identify these top decision factors:

1. Provider credentials and experience — 89% of patients rate provider qualifications as “very important” (RealSelf, 2024). Patients want to know the injector’s specific training, board certifications, and injection volume. AI provides generic advice about finding “a qualified provider” without helping patients evaluate specific practitioners.
2. Before-and-after results — 82% of patients want to see actual results before committing. RealSelf reports that before/after galleries are the #1 content type driving consultation bookings. AI cannot display visual results and rarely directs patients to specific provider galleries.
3. Pricing transparency — 78% of patients want clear pricing before consultation. The reality: medspa pricing is deliberately opaque at most practices (“call for a consultation”), which means AI has no accurate data to cite. This opacity hurts both the patient and the practice.
4. Location and convenience — 74% of patients want a medspa within 15–20 minutes of home or work (AmSpa, 2025). Aesthetic treatments often require multiple sessions and follow-up visits. AI gives national recommendations with no proximity filtering.
5. Reviews and reputation — 71% check online reviews across multiple platforms. RealSelf “Worth It” ratings, Google reviews, and Yelp reviews all factor into decisions. AI surfaces brands with the most aggregate online presence, not necessarily the best-reviewed local options.
6. Treatment-specific expertise — 67% of patients seek providers with specific expertise in their desired treatment (e.g., lip specialists, body contouring experts). AI rarely identifies treatment-specific specialists at the local level.
7. Consultation experience — 61% of patients cite the consultation experience as the final deciding factor. This is entirely offline and something AI cannot evaluate or convey.

The fundamental mismatch: aesthetic patients need hyper-local, credential-specific, visually-verifiable information. AI provides national, generic, text-based recommendations. This is the gap your medspa can fill — if AI knows you exist.

What actually works: the AI visibility playbook for medspas

The good news: AI visibility is a solvable problem. And because almost no one in the medspa industry is working on it yet, early movers have a disproportionate advantage. Here’s what works, based on our research into turning AI visibility data into action.

1. Audit what AI currently says about your practice

Before fixing anything, you need to know what’s broken. Query ChatGPT, Perplexity, Gemini, and Claude with prompts your patients would actually use:

• “What are the best medspas in [your city]?”
• “Tell me about [your practice name]”
• “How much does Botox cost in [your city]?”
• “Where should I get lip filler in [your city]?”
• “Is [your practice name] a good medspa?”
• “Best laser hair removal near [your neighborhood]”

Document every mention (or absence), every error, and every competitor that appears instead of you. Or run a Metricus AI visibility report that does this across hundreds of query variations automatically. For a quick start, try our free AI visibility check.

2. Publish data-rich, citable content

AI systems cite content that contains structured claims, statistics, and authoritative data. The GEO research from Princeton/Georgia Tech found that content with statistical citations was up to 40% more likely to be cited by generative AI.

For medspas, this means:

• Transparent pricing pages with specific per-unit and per-treatment costs, not “schedule a consultation.” Include year, effective date, and market context (“Our Botox is priced at $14/unit as of January 2026, compared to the [city] average of $16/unit per RealSelf data”). Pricing transparency is the single highest-impact content change most medspas can make for AI visibility.
• Provider credential pages with specific qualifications: board certifications with certifying body names, fellowship training, specific injection volume (“Dr. [Name] has performed over 10,000 Botox treatments since 2015”), continuing education, and membership in professional organizations (ASAPS, AAFPRS, ASDS). Numbers and specifics AI can extract and cite.
• Treatment pages with real data: Average number of units used for each treatment area, expected results timeline with specific days/weeks, contraindications, and “ideal candidate” criteria. Compare this to ASAPS national data so AI has context.
• Patient resource content: “Guide to Botox pricing in [your city]: 2026 data,” “How to choose a medspa: what credentials actually matter,” “Botox vs. Dysport vs. Xeomin: an injector’s comparison.” This positions your practice as an authoritative local source AI can cite.

3. Build citations on authoritative third-party sources

AI doesn’t just read your website. It reads everything about you across the web. The sources that carry the most weight for medspas:

• RealSelf provider profile with complete information, before/after photos, verified reviews, and “Worth It” ratings (this is the most important third-party platform for aesthetic medicine AI visibility)
• Google Business Profile with complete information, photos, and active review management (aim for 100+ reviews with consistent response)
• Healthgrades and Vitals provider profiles (if medical director is a physician)
• Yelp business profile with detailed service descriptions and photos
• Allergan/Galderma provider directories — being listed as a verified Allergan or Galderma provider carries authority
• AmSpa membership directory (American Med Spa Association)
• Local media and publications: guest columns in city magazines, local news features about aesthetic trends, community event coverage
• Reddit: AI heavily weights community discussions — genuine mentions in r/PlasticSurgery, r/Botox, r/SkincareAddiction, or local subreddits carry significant weight with AI models

4. Fix your structured data

Implement comprehensive schema markup on your website:

• MedicalBusiness schema for your practice (or LocalBusiness with “MedicalBusiness” type)
• MedicalProcedure schema for each treatment offered, with estimated cost ranges
• Physician schema for your medical director and providers, with credentials and specialties
• FAQPage schema for common patient questions (cost, recovery, candidacy, safety)
• Review and AggregateRating schema
• OpeningHoursSpecification for accurate hours
• GeoCoordinates for precise location data

Structured data helps AI systems understand what your business is, what treatments you offer, what your providers’ credentials are, and what makes you different — even when your website has less raw content than the national chains.

5. Correct errors at their source

If AI is getting your pricing, credentials, treatment offerings, or safety information wrong, the error is coming from somewhere. Usually it’s an outdated RealSelf profile, stale Yelp information, an old blog post about your practice, or inconsistent data across your own web properties. Common culprits include: a Groupon listing with outdated pricing still being indexed, a former provider’s credentials still on your website, or a directory listing showing treatments you no longer offer. Find the source, fix it, and the AI corrections will follow over time as models retrain on updated data.

6. Own the local treatment narrative

National chains win on volume. You can win on local authority. Create content that positions your practice as the definitive local source for aesthetic medicine information in your market:

• “The complete guide to Botox in [your city] — 2026 pricing, providers, and what to know”
• “[Your city] medspa comparison: treatments, credentials, and pricing transparency”
• “Body contouring options in [your city]: CoolSculpting vs. Emsculpt vs. Kybella”

This type of content serves two purposes: it makes you the local authority AI cites for market-specific queries, and it provides the kind of data-rich, comparison-based content that AI models preferentially cite.

The case for auditing your AI visibility now

The aesthetic medicine market is at an inflection point. The convergence of several trends makes this the right time to act:

Consumer demand is surging. ASAPS reports a 54% increase in minimally invasive cosmetic procedures between 2019 and 2024. The neurotoxin market alone grew 19% year-over-year in 2024. Millennials and Gen Z are driving new patient volumes at rates the industry has never seen. This growing demand means more patients are researching treatments online — and increasingly through AI.

The competitive landscape is consolidating. Private equity investment in aesthetic medicine practices exceeded $2 billion in 2024 (PitchBook data), with PE-backed platforms like SkinSpirit, Aesthetic Partners, and AestheticCare acquiring independent practices at an accelerating pace. These PE-backed groups have the resources to invest in digital content and AI visibility strategies. Independent medspas that don’t build their own AI presence risk being permanently outpaced.

AI adoption is accelerating in healthcare decisions. A 2025 McKinsey consumer health survey found that 31% of consumers had used an AI chatbot for health-related questions in the past year, up from 12% in 2023. For elective and cosmetic procedures — where patients are more comfortable self-researching — the figure is likely higher. Gartner’s prediction that traditional search volume will drop 25% by 2026 is already materializing in aesthetic treatment queries.

The medspas that understand their AI visibility now — while competitors are still relying exclusively on Google Ads and Instagram — will have a structural advantage that compounds over time. Every piece of authoritative, data-rich content you publish today enters the training data that shapes AI recommendations tomorrow.

The cost of waiting is real. The average medspa’s patient lifetime value (LTV) ranges from $3,000 to $12,000+ depending on treatment mix and retention (AmSpa benchmarking, 2025). Botox patients alone return 3–4 times per year, generating $1,500–$3,000 in annual recurring revenue per patient. Filler patients add $2,000–$5,000. Body contouring patients represent $3,000–$15,000. If even 5–10% of prospective patients are now starting their research with AI (a conservative estimate given the McKinsey data), and AI never mentions your practice, the revenue impact compounds rapidly.

For a medspa generating $2 million in annual revenue, 5% of new patient acquisition shifting to AI means approximately $100,000 in annual revenue is influenced by AI recommendations. If AI recommends a national chain or simply recommends the product without mentioning a provider, those patients never discover your practice. Over three years, that’s $300,000 in revenue at risk — from a single channel shift.

Multi-location medspa groups face an even larger calculation. A 10-location group with the same assumptions could see $1 million+ in annual revenue influenced by AI — with almost none of it flowing to their practices if AI doesn’t know they exist.

Sources: American Society for Aesthetic Plastic Surgery procedural statistics (ASAPS, 2024); American Med Spa Association industry study and benchmarking data (AmSpa, 2025); Grand View Research US medical spa market report (2025); McKinsey & Company “The Beauty Market in 2025” (2025); McKinsey consumer health AI survey (2025); Deloitte aesthetic medicine sector analysis (2024); AbbVie 2024 annual report and Allergan Aesthetics revenue data; Galderma 2024 annual report; American Society of Plastic Surgeons treatment cost data (ASPS, 2024); RealSelf patient survey and marketplace data (2024); PitchBook PE investment data in aesthetic medicine (2024); Gartner search prediction (Feb 2024); Pew Research Center AI adoption survey (2024); Kantar media spend estimates (2024); SEMrush search volume data (2025); SimilarWeb traffic estimates (2025); Princeton/Georgia Tech GEO study (Aggarwal et al., “GEO: Generative Engine Optimization,” 2023). AI mention rates based on Metricus internal testing across ChatGPT, Perplexity, Gemini, Claude, and Grok (2026). Learn more about how we measure AI visibility.

Related reading

• The 5-step AI visibility action plan — the general framework for turning audit findings into fixes.
• Fixing AI hallucinations about your brand — the deep dive on correcting factual errors at their source.
• What is AI visibility? — the complete explainer on how brands appear in AI.
• Why B2B SaaS brands are invisible in ChatGPT — the same dynamic in a different industry, with transferable strategies.
• Free AI visibility check — run a quick manual check before ordering a full report.
• AI visibility scores explained — how Metricus measures and benchmarks AI visibility.